Search results
Author(s):
Kazuya Hosokawa
,
Abe Kotaro
Added:
1 year ago
AHA 2023 — Dr Kazuya Hosokawa and Dr Abe Kotaro (Kyushu University Hospital, JP) join us to share the findings of the KABUKI trial (NCT04730037). The aim of KABUKI (Daiichi Sankyo) is to assess whether edoxaban, a direct factor Xa inhibitor, is noninferior to warfarin in preventing worsening of chronic thromboembolic pulmonary hypertension (CTEPH).This investigator-initiated, multicenter, phase 3…
View more
Author(s):
Ajitha Kulasekaran
,
Lorna Swan
Added:
2 years ago
Author(s):
Jenna Skowronski
,
Eleanor Christenson
,
Kayle Shapero
,
et al
Added:
1 month ago
Author(s):
Muhammad Asim Shabbir
,
Pradeep Yadav
,
Nidhish Tiwari
,
et al
Added:
1 year ago